Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription 06.02.2012 2 Am J Hematol 7 Blood 1 BMC Cancer 1 Bone Marrow Transplant 4 Br J Haematol 3 Cancer 2 Eur J Haematol 5 Exp Hematol 2 Int J Hematol 3 J Clin Oncol 1 J Natl Cancer Inst 1 J Pediatr Hematol Oncol 4 Leuk Lymphoma 14 Leuk Res 17 Leukemia 5 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hematol

1. MORI T , Aisa Y, Kato J, Yamane A, et al
   Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
   Am J Hematol. 2011 Dec 29. doi: 10.1002/ajh.23109.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CUNNINGHAM I
   A basis for updating our approach to resistant acute leukemia.
   Am J Hematol. 2011 Nov 16. doi: 10.1002/ajh.22256.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Blood

3. YOKOYAMA T , Toki T, Aoki Y, Kanezaki R, et al
   Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. WALTER RB , Appelbaum FR, Estey EH, Bernstein ID, et al
   Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.
   Blood. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. THOMSON KJ , Mackinnon S, Peggs KS
   CMV-specific cellular therapy for acute myeloid leukemia?
   Blood. 2012;119:1088-90.
   PubMed     Text format     Related articles   
   
   
   
6. PIGAZZI M , Masetti R, Martinolli F, Manara E, et al
   Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia.
   Blood. 2012;119:1086-7.
   PubMed     Text format     Related articles   
   
   
   
7. DEARDEN CE , Khot A, Else M, Hamblin M, et al
   Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.
   Blood. 2011;118:5799-802.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. WILLER A , Gerss J, Konig T, Franke D, et al
   Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
   Blood. 2011;118:5774-82.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. BAOU M , Norton JD, Murphy JJ
   AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.
   Blood. 2011;118:5732-40.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   BMC Cancer

10. SONG JH , Son SH, Lee JH, Chung SM, et al
    Defining the optimal dose of radiation in leukemic patients with extramedullary lesions.
    BMC Cancer. 2011;11:428.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Bone Marrow Transplant

11. KANDA Y , Sakamoto K, Ashizawa M, Sato M, et al
    Risks and benefits of ovarian shielding in female patients undergoing TBI: a decision analysis.
    Bone Marrow Transplant. 2011;46:1145-7.
    PubMed     Text format     Related articles   
    
    
    

    
    Br J Haematol

12. GIBSON BE , Webb DK, Howman AJ, De Graaf SS, et al
    Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial.
    Br J Haematol. 2011;155:366-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CHEN KW , Yang CF, Huang CT, Chiou TJ, et al
    Molluscum contagiosum in a patient with adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2011 Jun 17. doi: 10.1111/j.1365-2141.2011.08776.
    PubMed     Text format     Related articles   
    
    
    
14. WAN TS , Ma ES, Chen YT
    Near-tetraploid acute myeloid leukaemia.
    Br J Haematol. 2011;155:285.
    PubMed     Text format     Related articles   
    
    
    
15. SHEEN C , Vincent T, Barrett D, Horwitz EM, et al
    Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis.
    Br J Haematol. 2011;155:403-7.
    PubMed     Text format     Related articles   
    
    
    

    
    Cancer

16. STROM SS , Oum R, Elhor Gbito KY, Garcia-Manero G, et al
    De novo acute myeloid leukemia risk factors: A Texas case-control study.
    Cancer. 2012 Feb 1. doi: 10.1002/cncr.27442.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. HUANG X , Cortes J, Kantarjian H
    Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
    Cancer. 2012 Jan 31. doi: 10.1002/cncr.26679.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. FADERL S , Ravandi F, Huang X, Wang X, et al
    Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.
    Cancer. 2012 Jan 26. doi: 10.1002/cncr.27429.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Eur J Haematol

19. BOHME A , Atta J, Mousset S, Ehlken B, et al
    Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.
    Eur J Haematol. 2012;88:68-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LEVINSEN M , Shabaneh D, Bohnstedt C, Harila-Saari A, et al
    Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
    Eur J Haematol. 2012;88:78-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Exp Hematol

21. MILONE G , Avola G, Leotta S, Strano A, et al
    Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: association with CD34(+) mobilization and with disease-free survival.
    Exp Hematol. 2012;40:35-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. CUI XY , Wang N, Yang BX, Gao WF, et al
    HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.
    Exp Hematol. 2012;40:14-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. TAKEI F
    LAK cell therapy of AML: not to be lost in translation.
    Exp Hematol. 2011;39:1045-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. FRIKECHE J , Clavert A, Delaunay J, Brissot E, et al
    Impact of the hypomethylating agent 5-azacytidine on dendritic cells function.
    Exp Hematol. 2011;39:1056-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LARSEN HO , Roug AS, Nielsen K, Sondergaard CS, et al
    Nonviral transfection of leukemic primary cells and cells lines by siRNA-a direct comparison between Nucleofection and Accell delivery.
    Exp Hematol. 2011;39:1081-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J Hematol

26. GAVINI A , Telang GH, Olszewski AJ
    Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia.
    Int J Hematol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. TOMINAGA-SATO S , Tsushima H, Ando K, Itonaga H, et al
    Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
    Int J Hematol. 2011;94:81-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Oncol

28. BRUNET S , Labopin M, Esteve J, Cornelissen J, et al
    Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. XU H , Cheng C, Devidas M, Pei D, et al
    ARID5B Genetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. MARCUCCI G , Metzeler KH, Schwind S, Becker H, et al
    Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Natl Cancer Inst

31. GOOZNER M
    Radiation example and cancer: the Japanese example.
    J Natl Cancer Inst. 2011;103:1736.
    PubMed     Text format     Related articles   
    
    
    

    
    J Pediatr Hematol Oncol

32. CASH T , Becton D, Mian A
    Cardiac myeloid sarcoma: a case report and review of literature.
    J Pediatr Hematol Oncol. 2011;33:e330-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Leuk Lymphoma

33. ZHENG F , Li H, Li J, Du W, et al
    hERG1 K(+) channels regulated shedding of leukemia cell-derived microvesicles.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. PROCHOREC-SOBIESZEK M , Nasilowska-Adamska B, Borg K, Kopec I, et al
    Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene - a distinct clinical, pathological and genetic entity with potential treatment target?
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. WANG ES , Yee K, Koh LP, Hogge D, et al
    Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. DE VIRON E , Michaux L, Put N, Bontemps F, et al
    Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Leuk Res

37. CASTILLO JJ , Reagan JL, Ingham RR, Furman M, et al
    Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies.
    Leuk Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. XING H , Yang X, Liu T, Lin J, et al
    The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
    Leuk Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. HARDESTY BM , Cripe LD
    Cytarabine in relapsed acute myeloid leukemia.
    Leuk Res. 2012.
    PubMed     Text format     Related articles   
    
    
    
40. VAN DER HAVE N , Nath SV, Story C, Tapp H, et al
    Differential diagnosis of paediatric bone pain: Acute lymphoblastic leukemia.
    Leuk Res. 2012.
    PubMed     Text format     Related articles   
    
    
    
41. JAROSOVA M , Nedomova R, Hubacek J, Holzerova M, et al
    Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
    Leuk Res. 2012.
    PubMed     Text format     Related articles   
    
    
    
42. BROWN G , Hughes PJ, Ceredig R, Michell RH, et al
    Versatility and nuances of the architecture of haematopoiesis - Implications for the nature of leukaemia.
    Leuk Res. 2012;36:14-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. DUHOUX FP , Ameye G, Lambert C, Herman M, et al
    Novel head-to-head gene fusion of MLL with ZC3H13 in a JAK2 V617F-positive patient with essential thrombocythemia without blast cells.
    Leuk Res. 2012;36:e27-30.
    PubMed     Text format     Related articles   
    
    
    
44. NOVITZKY N , Thomas V
    In the absence of clinically significant graft vs. host disease, myeloablative conditioning may allow an effective graft vs. leukaemia effect.
    Leuk Res. 2012;36:104-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. SAI S , Watanabe C, Okada S
    A rare case of childhood precursor B-cell lymphoblastic lymphoma in the mandible.
    Leuk Res. 2012;36:e37-8.
    PubMed     Text format     Related articles   
    
    
    
46. ORLANDI EM , Rocca B, Pazzano AS, Ghio S, et al
    Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.
    Leuk Res. 2012;36:e4-6.
    PubMed     Text format     Related articles   
    
    
    
47. RAUH MJ , Rahman F, Good D, Silverman J, et al
    Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
    Leuk Res. 2012;36:81-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MATHEW RA , Bennett JM, Liu JJ, Komrokji RS, et al
    Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
    Leuk Res. 2012;36:72-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. BLACK JL , Litzow MR, Hogan WJ, O'Kane DJ, et al
    Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients.
    Leuk Res. 2012;36:59-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HAFERLACH T , Bacher U, Alpermann T, Haferlach C, et al
    Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.
    Leuk Res. 2012;36:51-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Leukemia

51. MI JQ , Wang X, Yao Y, Lu HJ, et al
    Newly diagnosed acute lymphoblastic leukemia in China (II): Prognosis related to genetic abnormalities in a series of 1 091 cases.
    Leukemia. 2012 Feb 2. doi: 10.1038/leu.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. POSPISILOVA S , Gonzalez D, Malcikova J, Trbusek M, et al
    ERIC recommendations on TP53 mutation analysis in Chronic Lymphocytic Leukemia.
    Leukemia. 2012 Feb 2. doi: 10.1038/leu.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. MATSUMURA T , Kami M, Yamaguchi T, Yuji K, et al
    Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan.
    Leukemia. 2012 Jan 17. doi: 10.1038/leu.2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. SPYRIDONIDIS A , Labopin M, Schmid C, Volin L, et al
    Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
    Leukemia. 2012 Jan 31. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. WOYACH JA , Lozanski G, Ruppert AS, Lozanski A, et al
    Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features.
    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
56. TUNG S , Spaner DE
    A role for Danazol in chronic lymphocytic leukemia.
    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
57. PORTER CC , Kim J, Fosmire S, Gearheart CM, et al
    Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.
    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. RENNEVILLE A , Boissel N, Nibourel O, Berthon C, et al
    Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. TEFFERI A , Pardanani A, Gangat N, Begna KH, et al
    Leukemia risk models in primary myelofibrosis: an International Working Group study.
    Leukemia. 2012 Jan 13. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
60. HOFMANN M , Grosse-Hovest L, Nubling T, Pyz E, et al
    Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.
    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. NAKAHATA S , Saito Y, Marutsuka K, Hidaka T, et al
    Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. DANESHMANESH AH , Hojjat-Farsangi M, Khan AS, Jeddi-Tehrani M, et al
    Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. ZUCCHETTO A , Vaisitti T, Benedetti D, Tissino E, et al
    The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
    Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SPIJKERS-HAGELSTEIN JA , Schneider P, Hulleman E, de Boer J, et al
    Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Leukemia. 2012 Jan 27. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. DE JONGE HJ , Woolthuis CM, Vos AZ, Mulder A, et al
    Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
    Leukemia. 2011;25:1825-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. ENOMOTO Y , Kitaura J, Hatakeyama K, Watanuki J, et al
    Emu/miR-125b transgenic mice develop lethal B-cell malignancies.
    Leukemia. 2011;25:1849-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. KOHLMANN A , Klein HU, Weissmann S, Bresolin S, et al
    The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.
    Leukemia. 2011;25:1840-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Semin Oncol

68. HSI ED
    Pathologic and molecular genetic features of chronic lymphocytic leukemia.
    Semin Oncol. 2012;39:74-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. MURAMATSU H , Makishima H, Maciejewski JP
    Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
    Semin Oncol. 2012;39:67-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. ERNST T , Hochhaus A
    Chronic Myeloid Leukemia: Clinical Impact of BCR-ABL1 Mutations and Other Lesions Associated With Disease Progression.
    Semin Oncol. 2012;39:58-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. BRUGGEMANN M , Gokbuget N, Kneba M
    Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle.
    Semin Oncol. 2012;39:47-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. BULLINGER L , Frohling S
    Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights.
    Semin Oncol. 2012;39:37-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: